Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“Some men just want to watch the world burn.”
That’s fine, stick around.
You’ll get real quiet when some of the big PRs start dropping, bet.
The 3PL company that we’re working with to distribute our drugs to those purchasing them? Seems like it might be based on some info from that site
Examples just looking around at other pharmas like Hikma and whoever Roxane is - other pharmas that received FDA approval letters dealing with first-to-file situations:
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/202090Orig1s000ltredt.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208339Orig1s000ltr.pdf
Looks like if patents are involved, the FDA mentions them and discusses how the company corresponded, such as if the applicant says they were invalidated or whatnot.
Case in point: I don’t think we’ll know if we are first-to-file on the Oxy ANDA until our approval letter or if we hear of another pharma getting it before then.
Lol now we both know that’s some fake news
Welcome. Plenty of goobers around here but we do what we can.
“Looks like Prasco has done nothing for Elite.”
Well the deal doesn’t kick in until 1/1/24, so… lol.
You’ll 100% be here after .15. Lol
Nah no chance he leaves. He’ll be here even after .15, guarantee it.
Sounds like you better sell then if you’re not confident in the company’s future.
Because institutional funds largely can’t own ELTP shares while it is a penny stock.
Because a chunk of brokerages won’t let you trade ELTP at all.
Because the company pivoted from its original abuse deterrent goal and probably scared off some would-be investors from a few rounds of overpromising and under delivering.
Because Elite had to dilute its shares to stay in business and continue funding new drugs, which drags on price.
Because stocks of all calibers go through periods of simply being undervalued or overvalued irrespective of fundamentals.
Because certain individuals admit to having engaged in shorting campaigns on Elite, which drags on price.
Because we’re on the OTC and during periods of extremely low volume, market makers will play games, which drags on price.
We have multiple drugs in the pipeline, plus already approved, that equal several billion dollars in market size. Nasrat is not going to sell the company for not even a double in share price from here when they’ve had independent valuations for over $1 years ago. Seriously, give it a rest.
Doesn’t matter what your personal price target is - it isn’t going to happen.
Everyone here knows, including you, that he isn’t going to sell for 15 cents. Give it a rest.
Like Nasrat said on the last call, they show their contracts and agreements to the DEA to justify the quota they get and the amount they ask for.
You’re also assuming the DEA wouldn’t raise the total “bucket” amount of quota for the industry to address the shortages.
IMO, not a game changer but certainly another positive coming soon and should be the next approval we see, likely in October.
I expect Kirko will also make it another worthwhile generic pursuit. Another arrow in Elite’s quiver!
So to be clear - you “own” 20,000 shares but you want the stock to delist and go to .0001?
Lol who are these amateur clowns
Dude got hooked up. Lol.
Now he better get to work on fixing the stupid March-March fiscal year!
I wondered. Lol. No worries.
I myself am neither. If you are referring to someone else, then yes I think one or both of those may apply to many IDs on this board.
Several things
You can probably guess why. Boiler
Traitor is a bit harsh. If he got an offer for double his salary elsewhere, I won’t fault the guy for taking it.
IMO, better to bring someone back who knows the company very well and will hit the ground running than some of the other clowns that have recently filled the position.
The ELTP Eeyore
So Hikma does or doesn’t have 180 day exclusivity from 8/24/23 then?
Easily proved accusation when one has the proof on multiple other platforms as the person uses the same name throughout. 🧠
Way beneath the moral code of someone such as James, I suspect.
Definitely the best. IMO, James would never stalk and spam someone for over a year on multiple different platforms with literally zero to gain from it. That would be highly psychotic and disturbing. Be more like James.
Elite actually does make Loxapine and Trimipramine that could help those very troubled individuals.
Doesn’t act like a scumbag stalker basement dweller either. Positives for James all around!
I concur, James sounds like an actual human with a valuable perspective from the pharmacy side and not a boiler room rat.
What clown would supposedly hold this viewpoint of a company and then either buy new shares or continue holding shares previously purchased. Lol.
(No one)
Pivoting from the ADT strategy as basically a singular focus, while painful for shareholders at the time, turned out to be a brilliant move. We’re in a much better spot now fundamentally than we ever were before.
And the future looks brighter than ever.
Definitely a much bigger deal for Oxy although I do think having Kirko will make every single drug of ours more valuable.
I do hope you’re right and that they indicate the specific PDUFA dates for all 3 of the heavy hitters coming up!
Don’t think the PDUFA date is listed in the press release. At least it hasn’t been for the last 2 they told us about - the antimetabolite or the dopamine agonist.
I’m looking forward to the fiscal being reset to normal calendar year. March-March is weird.
Any idea how that transition works? Do we then have a year of only 3 quarters?
Funny little coinkydink I’m sure
Consultants/temps can be brought in to handle the finances until a permanent hire is picked.
Kirko more than makes up for a couple poor CFOs, IMO.
Seeking Alpha commenting on our news, just a rehash of Elite’s PR:
https://stocks.apple.com/AVGfeA8mEQRunXzt1zfX8QA
It is a worthwhile point of view / source of information, IMO. Thanks for your contributions!
So filed in Oct-Nov, approved maybe Oct-Nov 2024 you think?
Is Vyvanse the largest in the CNS stimulant category, do you know?